ReviewMolecular therapy. Oncology2025
Reversing regulatory safeguards: Targeting the ATR pathway to overcome PARP inhibitor resistance.
Xixi Lin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it